Protocol Ledger

NCT05201469 · Phase II · RECRUITING

VIBRANT: VIB4920 for Active Lupus Nephritis

Interventional Phase II clinical trial protocol NCT05201469 sponsored by National Institute of Allergy and Infectious Diseases (NIAID) in Immunology, Rheumatology, and Dermatology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-12-15 Enrollment: 74 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05201469
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)74 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05201469
Protocol FieldVerified Registry Value
NCT IdentifierNCT05201469
Consolidated Lead SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Therapeutic Condition CohortImmunology, Rheumatology, and Dermatology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment74 participants (ESTIMATED)
Registered Start Date2022-12-15
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Immunology, Rheumatology, and Dermatology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI